Pyrano indolizino quinoléine dérivé And NotC. Riche
List of bibliographic references
Number of relevant bibliographic references: 5.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 005750 | Joachim Von Pawel [Allemagne, France, Royaume-Uni, Australie, États-Unis] ; Ulrich Gatzemeier ; Jean-Louis Pujol ; Lionel Moreau ; S. Bildat ; Malcolm Ranson ; Gary Richardson ; Claus Steppert ; Alain Riviere ; Ina Camlett ; Stephen Lane ; Graham Ross | Phase II comparator study of oral versus intravenous topotecan in patients with chemosensitive small-cell lung cancer |
| 005D48 | H. M. Dodds [Australie] ; S. J. Clarke [Australie] ; M. Findlay [Nouvelle-Zélande] ; J. F. Bishop [Australie] ; J. Robert [France] ; L. P. Rivory [Australie] | Clinical pharmacokinetics of the irinotecan metabolite 4-piperidinopiperidine and its possible clinical importance |
| 006239 | H. M. Dodds [Australie] ; J. Robert [France] ; L. P. Rivory [Australie] | The detection of photodegradation products of irinotecan (CPT-11, Campto®, Camptosar®), in clinical studies, using high-performance liquid chromatography/atmospheric pressure chemical ionisation/mass spectrometry |
| 006658 | L. P. Rivory [Australie] ; M.-C. Haaz [France] ; P. Canal [France] ; F. Lokiec [France] ; J.-P. Armand [France] ; J. Robert [France] | Pharmacokinetic interrelationships of irinotecan (CPT-11) and its three major plasma metabolites in patients enrolled in phase I/II trials |
| 006935 | L. P. Rivory [Australie, France] ; J.-F. Riou [États-Unis] ; M.-C. Haaz [France] ; S. Sable [États-Unis] ; M. Vuilhorgne [États-Unis] ; A. Commercon [États-Unis] ; S. M. Pond [Australie] ; J. Robert [France] | Identification and properties of a major plasma metabolite of irinotecan (CPT-11) isolated from the plasma of patients |
| This area was generated with Dilib version V0.6.33. |  |